Antonios Valachis

Oerebro, T, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 80 publications

Plain language summary about how patients with HER2 positive breast cancer across Europe feel about their cancer, treatment, and future health and related implications for their treatment journey.

Plain language summary about how patients with HER2 positive breast cancer across Europe feel about their cancer, treatment, and future health and related implications for their treatment journey.

Journal: Future oncology (London, England)

Published: May 13, 2026

Variation in chemotherapy use across healthcare regions in Sweden and its impact on prognosis in women with HR+/HER2- early breast cancer.

Variation in chemotherapy use across healthcare regions in Sweden and its impact on prognosis in women with HR+/HER2- early breast cancer.

Journal: Breast cancer research : BCR

Published: April 30, 2026

Balancing clinical relevance, legal boundaries, and technological solutions: a case-based analysis of secondary use of electronic health records in Sweden.

Balancing clinical relevance, legal boundaries, and technological solutions: a case-based analysis of secondary use of electronic health records in Sweden.

Journal: ESMO real world data and digital oncology

Published: April 03, 2026

Optimizing the clinical assessment of pseudoprogression in patients with solid tumors treated with checkpoint inhibitors: a systematic literature review and meta-analysis of associated features.

Optimizing the clinical assessment of pseudoprogression in patients with solid tumors treated with checkpoint inhibitors: a systematic literature review and meta-analysis of associated features.

Journal: Cancer immunology, immunotherapy : CII

Published: March 19, 2026

A nationwide population-based study on the incidence and prognosis of HER2-positive breast cancer eligible for adjuvant pertuzumab in the modern era of neoadjuvant therapy.

A nationwide population-based study on the incidence and prognosis of HER2-positive breast cancer eligible for adjuvant pertuzumab in the modern era of neoadjuvant therapy.

Journal: Breast (Edinburgh, Scotland)

Published: February 14, 2026

Neoadjuvant Immunotherapy Using PD-1 Inhibitors for Resectable Stage III Cutaneous Melanoma-Different Outcomes Between Patients With Lymph Node and In-transit Metastases.

Neoadjuvant Immunotherapy Using PD-1 Inhibitors for Resectable Stage III Cutaneous Melanoma-Different Outcomes Between Patients With Lymph Node and In-transit Metastases.

Journal: Annals of surgery

Published: February 06, 2026

Bridging the gap: overcoming barriers to implementing gene expression profiling in clinical practice.

Bridging the gap: overcoming barriers to implementing gene expression profiling in clinical practice.

Journal: ESMO real world data and digital oncology

Published: February 06, 2026

Omission of axillary lymph node dissection in ultrasound-detectable axillary metastases in primary breast cancer treated by upfront surgery: prospective randomized SENOMAC-ULTRA non-inferiority trial.

Omission of axillary lymph node dissection in ultrasound-detectable axillary metastases in primary breast cancer treated by upfront surgery: prospective randomized SENOMAC-ULTRA non-inferiority trial.

Journal: BJS open

Published: January 26, 2026

FOCU.SE trial: a nationwide Swedish drug repurposing protocol and research framework.

FOCU.SE trial: a nationwide Swedish drug repurposing protocol and research framework.

Journal: Acta oncologica (Stockholm, Sweden)

Published: January 23, 2026

PREDICT v3.0 outperforms v2.2 in young (25-40 years) breast cancer patients according to real-world data from a large Swedish population-based registry.

PREDICT v3.0 outperforms v2.2 in young (25-40 years) breast cancer patients according to real-world data from a large Swedish population-based registry.

Journal: Breast cancer research : BCR

Published: January 12, 2026

Clinical and economic impact of incisional negative pressure wound therapy in breast surgery: meta-analysis.

Clinical and economic impact of incisional negative pressure wound therapy in breast surgery: meta-analysis.

Journal: The British journal of surgery

Published: January 08, 2026

Assessing Overall Survival Benefits in Advanced Cancers: The Role of External Comparator Cohort Studies with Real-World Data.

Assessing Overall Survival Benefits in Advanced Cancers: The Role of External Comparator Cohort Studies with Real-World Data.

Journal: Clinical pharmacology and therapeutics

Published: November 08, 2025

Showing 1-12 of 80

Last Updated: 09/26/2026